Your browser doesn't support javascript.
loading
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai, Jayesh; Alonso, Guzman; Kim, Se Hyun; Cervantes, Andres; Karasic, Thomas; Medina, Laura; Shacham-Shmueli, Einat; Cosman, Rasha; Falcon, Alejandro; Gort, Eelke; Guren, Tormod; Massarelli, Erminia; Miller, Wilson H; Paz-Ares, Luis; Prenen, Hans; Amatu, Alessio; Cremolini, Chiara; Kim, Tae Won; Moreno, Victor; Ou, Sai-Hong I; Passardi, Alessandro; Sacher, Adrian; Santoro, Armando; Stec, Rafal; Ulahannan, Susanna; Arbour, Kathryn; Lorusso, Patricia; Luo, Jia; Patel, Manish R; Choi, Yoonha; Shi, Zhen; Mandlekar, Sandhya; Lin, Mark T; Royer-Joo, Stephanie; Chang, Julie; Jun, Tomi; Dharia, Neekesh V; Schutzman, Jennifer L; Han, Sae-Won.
Afiliación
  • Desai J; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. jayesh.desai@petermac.org.
  • Alonso G; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Kim SH; Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Cervantes A; Hospital Clinico Universitario De Valencia, Valencia, Spain.
  • Karasic T; Abramson Cancer Center, University Of Pennsylvania, Philadelphia, PA, USA.
  • Medina L; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • Shacham-Shmueli E; Sheba Medical Center, Sackler School of Medicineó, Tel Aviv University, Tel Aviv, Israel.
  • Cosman R; The Kinghorn Cancer Centre, St. Vincent's Hospital and School of Medicine, University of New South Wales, Sydney, Australia.
  • Falcon A; Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Gort E; Universitair Medisch Centrum Utrecht, Utrecht, Netherlands.
  • Guren T; Oslo University Hospital Radiumhospitalet, Oslo, Norway.
  • Massarelli E; City of Hope - Comprehensive Cancer Center, Duarte, CA, USA.
  • Miller WH; Lady Davis Institute and Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Paz-Ares L; Hospital Universitario 12 de Octubre, H120-CNIO Lung Cancer Unit, Universidad Complutense and Ciberonc, Madrid, Spain.
  • Prenen H; University Hospital Antwerp, Edegem, Belgium.
  • Amatu A; Haematology and Oncology Division, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cremolini C; University of Pisa, Pisa, Italy.
  • Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Moreno V; START MADRID-FJD, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain.
  • Ou SI; University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, USA.
  • Passardi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
  • Sacher A; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada, Department of Medicine & Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Santoro A; Humanitas University and IRCCS Humanitas Research Hospital-Humanitas Cancer Center, Milan, Italy.
  • Stec R; Biokinetica, Przychodnia Jozefow, Józefów, Poland.
  • Ulahannan S; Warsaw Medical University, Warsaw, Poland.
  • Arbour K; Stephenson Cancer Center, Oklahoma City, OK, USA.
  • Lorusso P; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Luo J; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.
  • Patel MR; Yale Cancer Center, Yale University, New Haven, CT, USA.
  • Choi Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Shi Z; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, USA.
  • Mandlekar S; Genentech, South San Francisco, CA, USA.
  • Lin MT; Genentech, South San Francisco, CA, USA.
  • Royer-Joo S; Genentech, South San Francisco, CA, USA.
  • Chang J; Genentech, South San Francisco, CA, USA.
  • Jun T; Genentech, South San Francisco, CA, USA.
  • Dharia NV; Genentech, South San Francisco, CA, USA.
  • Schutzman JL; Genentech, South San Francisco, CA, USA.
  • Han SW; Genentech, South San Francisco, CA, USA.
Nat Med ; 30(1): 271-278, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38052910
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Proteínas Proto-Oncogénicas p21(ras) Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Australia